Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...

To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...

The elephant vaccine closely resembles other mRNA vaccines made for humans. mRNA packed in lipid nanoparticles carries ...

To overcome the inherent challenge of translation termination interference caused by stop codon reprogramming in mammalian ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the most active stocks to buy according to analysts. On June 13, Ethris ...

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

Liquid-liquid phase separation (LLPS) has emerged as a major organizing principle in cells. Recent work showed that multiple components of integrin-mediated focal adhesions, including p130Cas can form ...

Researchers develop a self-regulating mRNA medicine that adjusts protein production based on disease-related signals. A research team from The University of Osaka and Institute of Science Tokyo ...

The mRNA, or messenger RNA, in the vaccines provides instructions for cells to make small quantities of spike protein from the coronavirus, preparing the immune system to recognize the actual ...

The global mRNA vaccines and RNAi therapeutics market size was US$ 707.9 million in 2021. The global mRNA vaccines and RNAi therapeutics market size is estimated to reach US$ 8210.2 million by 2030, ...